Fine needle Aspiration Biopsy (FNAB) in the initial evaluation and diagnosis of palpable soft tissue lesions and with histologic correlation

Fine needle Aspiration Biopsy (FNAB) in the initial evaluation and diagnosis of palpable soft tissue lesions and with histologic correlation

 

Gabriel Olabiyi Ogun^1,&

 

¹Department of Pathology, College of Medicine, University of Ibadan/ University College Hospital, Ibadan, Nigeria

 

 

^&Corresponding author
Gabriel Olabiyi Ogun, Department of Pathology, College of Medicine, University of Ibadan/ University College Hospital, Ibadan, Nigeria

 

 

 

 

Palpable soft tissue masses are quite common in clinical practice. The use of Fine needle aspiration biopsy (FNAB) remains highly underutilized in our environment despite the fact that it safe, cheap, quickly, easy to perform and not usually fraught with complications [1, 2]. The FNAB is handy as a means of early diagnosis and help prevent unnecessary and expensive open biopsies [3,4]. With increasing knowledge, experience and training in the use of FNAB in the diagnosis of soft tissue lesions and palpable lumps in other parts of the body, it is increasingly becoming common place in the practice of cytopathology in some Sub-saharan Africa countries and globally [5-7]. Many reports from different parts of the world suggest that the FNAB has high diagnostic accuracy and value in experienced hands [1, 7-9]. The issue of cost is more important and significant in sub-Saharan and developing African countries where there are many competing needs for limited funds allocated to health care on the part of government and also from patients who pay for health care out-of-pocket [3, 10]. The aim of this study was to assess the diagnostic efficacy of the use of FNAB as an initial assessment tool for palpable soft tissue lumps and swelling in the trunk and extremities, determine the accuracy of FNAB and correlate the final cytologic diagnosis with the histopathologic diagnosis in patients that ultimately had open tissue biopsy performed.

 

 

The records of consecutive palpable soft tissue lesions of the trunk and extremities which had FNAB performed as at the fine needle aspiration cytology clinic of the Department of pathology University College Hospital were reviewed for a period 5 years. All cases included for analysis had adequate smears in terms of material available on the slides for assessment. Lesions in the head and neck, the breast, lymph nodes, intraabdominal and intrathoracic locations were excluded from the study. Only cases with sufficient clinical information and a definitive final cytologic diagnosis were included in the study. Furthermore, records for corresponding cases that had open excision biopsy out of these cases were also retrieved. All the cytology smears and histology were reviewed by the author to ascertain the correctness of diagnosis.

 

A registered nurse was always in attendance during the procedure and served as chaperone. The cytology material is usually obtained by conventional method of fine needle aspiration using either a 21 or 23 gauge needle attached to a 10ml disposable plastic syringe. Negative pressure is created by pulling the plunger once the needle is inserted into the nodule or mass and firm suction applied with short strokes in different directions in the lesion depending on the size of the lesion. Material obtained by the aspiration is expelled onto glass slides and smears made with another glass slide on a minimum of three slides, two of which were fixed immediately in 95% alcohol for a minimum of 30 minutes and one air dried. In some cases more than three slides were made for each aspiration. The immediately fixed slides are routinely stained with Papanicolaou staining method while the air dried slides are stained with May Grunwald-Giemsa (MGG) stain and occasionally with haematoxylin and eosin (H&E) stains. Sometimes, the FNAB is repeated if the material obtained at the first aspirate is not adequate for cytologic assessment. All adequate smears were group into three broad categories - benign, malignant and suspicious of malignancy. Furthermore all adequate smears were reclassified during the review by the author based on cytomorphologic features into lipomatous, epithelia, spindle cell, inflammatory, pleomorphic, small round cell, myxoid, epitheloid/polygonal and other lesions [1]. Also anatomic location of the lesions were stratified into the trunk, upper limb (upper arm, fore arm and hand) and lower limb (thigh, leg and foot). This study was conducted in compliance with the guidelines of the Helsinki declaration on biomedical research in human subjects. Confidentiality of the identity of the patients and personal health information was maintained.

 

 

There were a total of 142 soft tissue lesions assessed for this study from 141 patients.(A patient had two lesions). However only 107 (75.3% of cases assessed) palpable soft tissue lesions in 107 patients fulfilled the inclusion criteria and were suitable for analysis. The rest were either inadequate for diagnosis (12%) or did not have enough clinical information. There were 56 males and 51 females giving a roughly equal male: female ratio. The age range for the patients was from 0 - 85years with a mean age of 41.2 years. Figure 1 show the age group distribution of the patients. The lesions were located in the trunk -56 cases, upper arm -7, forearm -1, hand -1, thigh -28, leg -7 and the foot-7. The final cytologic diagnosis was benign in 56 (52.3%) cases, malignant in 48 (44.8%) cases and suspicious of malignancy in 3(2.8%) cases. Table 1 shows the cytomorphologic classification of the final cytologic diagnosis into benign, malignant and suspicious of malignancy. From Table 1, of the 18 cases are classified as epithelia lesions, 16 of which were diagnosed as metastatic carcinomas. Only 40 (37.8%) of cases that had FNAB as the initial evaluation of palpable soft tissue lesion had open biopsy as a management modality from our records. Hence they had a histologic diagnosis. Table 2 show details of cases that had histology done and the final histologic diagnosis. The correlation tests between the broad final cytologic diagnosis (benign, malignant and suspicious of malignancy) and the histologic diagnosis in those that had open biopsy are as follow- there were 19 true positives (FNAB malignant and histologic diagnosis malignant); and 20 true negatives (FNAB benign and histologic diagnosis benign). There was no false positive case (FNAB malignant and histologic diagnosis benign) and 1 false negative case (FNAB benign and histologic diagnosis malignant) thereby giving a false negative rate of 2.5%. The sensitivity and specificity of diagnosed palpable soft tissue lesions of the trunk and extremities with FNAB across the Benign and Malignant classification, with histology as the gold standard for diagnosis were 95% and 100% respectively. The positive predictive value (PPV and negative predictive value (NPV) were 100% and 95% respectively. The overall accuracy of FNAB with histologic correlation was 97.5%.

 

 

This study illustrates the high efficacy of the FNAB in discriminating between benign and malignant palpable soft tissue lesions by an accuracy of 97.5% when a correlation with open biopsy for the same cases is performed. This is quite critical and important in streamlining patients' management and making clinical decisions. However, the limitation of the FNAB is obvious because of the varied lesions in Table 2 that can present as palpable soft tissue lesions, which include primary and secondary neoplastic lesions, inflammatory and reactive lesions as indicated from the histologic diagnosis. This study illustrates that FNAB can be used in all age group of patients. However, it was disappointing that only 40 cases representing 37.8% of patients that had FNAB had histology diagnosis we could compare with. This relatively low number of excision biopsy may be due to a number of reasons including - patient not having excision biopsy at all, FNAB diagnosis and clinical course with radiologic follow up was satisfactorily benign and patients completely lost to follow up or died before open biopsy. This study indicated that 12% of the cases were inadequate for cytologic diagnosis; this is similar to 17% reported by Layfield et al [11]. The reasons that might account for inadequate aspirates include poor technique, necrosis or cystic change in malignant lesions; and in lesions like desmoids and keloids which are fibroblastic and aspiration of material for cytolopathologic diagnosis is difficult from such lesions [11-13].

 

In this study the sensitivity and specificity of FNAB in stratifying soft tissue lesions into benign and malignant lesions were 95% and 100% respectively and. There was a single case of false negativity giving a 2.5% rate and no false positive case. Wakely and Kneisl in a series of 82 cases of soft tissue lesions analysed by FNAB reported a sensitivity and specificity of 100% and 97% respectively and a single false negative case; a result which is similar to that of the current study [12]. Also, Layfield et al and Nagira et al in their studies of FNAB of soft tissue lesions, reported sensitivity and specificity that range from 92% to 97% [1, 11]. This current study show similar findings to that of Kilpatrick et al, they reported one false negative case and no false- positive case in a study of 145 consecutive sarcomas of bone and soft tissue while Akerman and Rydholm in a study of 517 soft tissue tumors reported a false negative rate of 2.9% and false positive rates of 2.9% [6, 14]. The positive and negative predictive value of 100% and 95% in this study is similar to those of Nagira et al who recorded 93% and 96% respectively [1].

 

The results in Table 2 illustrate the obvious superiority of Open biopsy with subsequent histologic diagnosis after an initial FNAB assessment. Based on cytomorphology, this superiority is most obvious considering the pleomorphic lesions. These lesion are varied and with widely different histogenesis of the tumours. Our findings are similar to those previously observed and reported [1,15-17]. Nagira et al and Klijanienko et al reported only 24.2% and 28% of cases of Pleomorphic lesions were rendered precisely by FNAB when correlated with histologic diagnosis [1,17]. In the current study, all epithelia lesions especially metastatic carcinomas were precisely diagnosed on FNAB when correlated with histology. This is easily attainable in cytopathology practice, when the diagnosis is correlated with clinical history of the patient. The precise FNAB diagnosis in lipomatous lesions was correct in 13 of the 16 cases in the present series. All the 13 cases were lipomas. In this study there was no record of liposarcomas on histology to correlate with FNAB. The findings regarding FNAB and histologic correlation in lipomas are similar to those of Nagira et al [1]. In summary FNAB smears of 107 cases and 40 corresponding histologic cases were examined. The sensitivity and specificity of FNAB across the benign and malignant stratification was 95% and 100% respectively and with a PPV and NPV of 100% and 95% respectively.

 

 

FNAB is a valuable tool in clinical medical practice in stratifying palpable soft tissue lesions into benign and malignant categories and. It can be used in the initial evaluation of all palpable soft tissue lesions especially in primary soft tissue neoplasms and clinically suspected metastatic carcinomas.

 

 

The author declares no competing interests.

 

 

GOO conceived the idea of the manuscript, collated and analyzed the data and wrote the manuscript.

 

 

Table 1: cytomorphologic classification of the final cytologic diagnosis of 107 cases

Table 2: details of cases that had histology done and with the final histologic diagnosis

Figure 1: age group distribution of patients that had FNAB as initial evaluation of soft tissue lesion of the trunk and extremities

 

 

1. Nagira K, Yamamoto T, Akisue T, Marui T, Hitora T, Nakatani T, et al. Reliability of fine-needle aspiration biopsy in the initial diagnosis of soft-tissue lesions. Diagn Cytopathol. 2002 Dec;27(6):354-61. PubMed | Google Scholar


2. Thomas JO, Adeyi D, Amanguno H. Fine-needle aspiration in the management of peripheral lymphadenopathy in a developing country. Diagn Cytopathol. 1999 Sep;21(3):159-62. PubMed | Google Scholar


3. Thomas JO, Amanguno AU, Adeyi OA, Adesina AO. Fine needle aspiration (FNA) in the management of palpable masses in Ibadan: impact on the cost of care. Cytopathol. 1999 Jun;10(3):206-10. PubMed | Google Scholar


4. Thomas JO, Adeyi OA, Nwachokor FN, Olu-Eddo AO. Fine needle aspiration cytology in the management of thyroid enlargement: Ibadan experience. East Afr Med J. 1998 Nov;75(11):657-9. PubMed | Google Scholar


5. Ward WG, Savage P, Boles CA, Kilpatrick SE. Fine-needle aspiration biopsy of sarcomas and related tumors. Cancer Control J Moffitt Cancer Cent. 2001 Jun;8(3):232-8. PubMed | Google Scholar


6. Kilpatrick SE, Cappellari JO, Bos GD, Gold SH, Ward WG. Is fine-needle aspiration biopsy a practical alternative to open biopsy for the primary diagnosis of sarcoma? Experience with 140 patients. Am J Clin Pathol. 2001 Jan;115(1):59-68. PubMed | Google Scholar


7. Florentine BD, Staymates B, Rabadi M, Barstis J, Black A, Cancer Committee of the Henry Mayo Newhall Memorial Hospital. The reliability of fine-needle aspiration biopsy as the initial diagnostic procedure for palpable masses: a 4-year experience of 730 patients from a community hospital-based outpatient aspiration biopsy clinic. Cancer. 2006 Jul 15;107(2):406-16. PubMed | Google Scholar


8. Kilpatrick SE, Ward WG, Cappellari JO, Bos GD. Fine-needle aspiration biopsy of soft tissue sarcomas-A cytomorphologic analysis with emphasis on histologic subtyping, grading, and therapeutic significance. Am J Clin Pathol. 1999 Aug;112(2):179-88. PubMed | Google Scholar


9. Willén H, Akerman M, Carlén B. Fine needle aspiration (FNA) in the diagnosis of soft tissue tumours; a review of 22 years experience. Cytopathol. 1995 Aug;6(4):236-47. PubMed | Google Scholar


10. Afolabi AO, Oluwasola AO, Akute OO, Akang EEU, Ogundiran TO, Ogunbiyi JO, et al. Review of fine needle aspiration cytology in the management of goitres in Ibadan, Nigeria. Niger J Clin Pract. 2010 Jun;13(2):163-6. PubMed | Google Scholar


11. Layfield LJ, Anders KH, Glasgow BJ, Mirra JM. Fine-needle aspiration of primary soft-tissue lesions. Arch Pathol Lab Med. 1986 May;110(5):420-4. PubMed | Google Scholar


12. Wakely PE Jr, Kneisl JS. Soft tissue aspiration cytopathology. Cancer. 2000 Oct 25;90(5):292-8. PubMed | Google Scholar


13. Akerman M, Rydholm A, Persson BM. Aspiration cytology of soft-tissue tumors. The 10-year experience at an orthopedic oncology center. Acta Orthop Scand. 1985 Oct;56(5):407-12. PubMed | Google Scholar


14. Akerman M, Rydholm A. Surgery based on fine needle aspiration cytology. Acta Orthop Scand. 1994;65(Suppl 256):69-70. PubMed | Google Scholar


15. Berardo MD, Powers CN, Wakely PE Jr, Almeida MO, Frable WJ. Fine-needle aspiration cytopathology of malignant fibrous histiocytoma. Cancer. 1997 Aug 25;81(4):228-37. PubMed | Google Scholar


16. Powers CN, Berardo MD, Frable WJ. Fine-needle aspiration biopsy: pitfalls in the diagnosis of spindle-cell lesions. Diagn Cytopathol. 1994;10(3):232-240; discussion 241. PubMed | Google Scholar


17. Klijanienko J, Caillaud J-M, Lagacé R, Vielh P. Comparative fine-needle aspiration and pathologic study of malignant fibrous histiocytoma: cytodiagnostic features of 95 tumors in 71 patients. Diagn Cytopathol. 2003 Dec;29(6):320-6. PubMed | Google Scholar